Searched for
DR T JACOB JOHN
Eric Dane suffering from ALS, to continue work on EuphoriaEric Dane, famed for his role in Grey's Anatomy, has been diagnosed with ALS. He shared this news, expressing gratitude for his family's su...- India on alert as 21 new cases of JN.1 Covid subvariant reported: Here's what doctors adviseIndia remains on alert following the emergence of the JN.1 COVID-19 subvariant, with 21 reported cases nationwide. The WHO labeled JN.1 a '...
- Can recent Covid increase lead to another 'wave'? Here's what virologist saidDespite the surge in Covid-19 cases in Kerala, the majority of patients are recuperating without needing medical intervention. However, is ...
- Probability of 4th COVID wave extremely low but need to be vigilant, cautions Virologist Jacob JohnDr John also said that he doesn't believe in predicting waves based on mathematical modelling.
- No fourth wave of coronavirus will occur in India: Virologist T Jacob JohnThe third wave of COVID-19 had plateaued in India and the number of cases started declining after January 21 when 3,47,254 infections were ...
- Covid can be said to have become endemic only after 4 weeks of consistently low cases: Virologist Dr T Jacob John"When case numbers in a community are plotted on graphs, the pattern of rise, peak and fall represent epidemic (or outbreak) and case numbe...
- Two years on, India's battle with COVID-19, its variants continues with no end in sightTill now, India has reported 4,10,92,522 cases and 4,94,091 fatalities due to COVID-19 and its variants. According to the Indian SARS-COV-2...
- Omicron a 'deviant', two pandemics going on side by side now: Virologist T Jacob John"Since Omicron is illegitimate or 'deviant' from COVID-19 pandemic progression script, we must think of two pandemics going on side by side...
- High temperature, drying can reduce infectivity of viruses, including coronavirus: Experts"A decrease in infectivity to approximately 10 per cent of the starting value was observable for SARS-CoV-2 over 20 minutes, with a large p...
- Booster dose increases antibodies, improves protection against Omicron, say scientistsThe Health Ministry told the Lok Sabha last week that the National Expert Group on Vaccine Administration for COVID-19 (NEGVAC) and the Nat...
- Covid-19: India’s Covid R-naught tops 1 again, up from 0.9 a month agoThe R-value is a tool epidemiologists and policy makers use to check if cases are growing faster or shrinking quickly. The reproduction fac...
- What you should know about the Delta variant: It's more contagious, likely to defeat vaccine immunityStudies have shown that the available vaccines work against the delta variant.
- Covid: Tamil Nadu's numbers peak is around the corner, says virologist Jacob JohnWhen asked how cases were going up despite a complete lockdown in the State, John remained unfazed. He said that cases were going up due to...
- COVID-19 vaccine to be supplied free of cost in govt health facilities: Punjab CMKeeping in view the limited supplies of vaccine expected initially, the chief minister constituted an expert group, comprising eminent viro...
- Buy Muthoot Finance, target Rs 555: Dr CK NarayanBuy Muthoot Finance Ltd. at a price target of Rs 555.0 and a stoploss at Rs 538 from entry point.
- Buy Muthoot Finance, target Rs 527: Dr CK NarayanBuy Muthoot Finance Ltd. at a price target of Rs 527.0 and a stoploss at Rs 508 from entry point.
- Buy Muthoot Finance, target Rs 414: Dr CK NarayanBuy Muthoot Finance Ltd. at a price target of Rs 414.0 and a stop loss at Rs 396 from entry point.
- Buy Muthoot Finance, target Rs 510: Dr CK NarayanBuy Muthoot Finance at a price target of Rs 510 and a stop loss at Rs 490 from entry point.
- Buy Muthoot Finance, target Rs 396: Dr CK NarayanBuy Muthoot Finance Ltd. at a price target of Rs 396.0 and a stop loss at Rs 380.0 from entry point
- Hepatitis B vaccine’s efficacy in doubtThe vaccination aims to reduce the number of chronic carriers who could infect others and themselves develop liver cancers or cirrhosis lat...
Load More
